JY
ACHV icon

Jeff Yass’s Achieve Life Sciences ACHV Stock Holding History

Jeff Yass’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.77M Buy
577,500
+492,600
+580% +$2.35M ﹤0.01% 5169
2026
Q1 		$250K Buy
84,900
+50,700
+148% +$225K ﹤0.01% 11271
2025
Q4 		$170K Sell
34,200
-37,900
-53% -$165K ﹤0.01% 11049
2025
Q3 		$227K Buy
72,100
+61,500
+580% +$169K ﹤0.01% 10719
2025
Q2 		$24K Buy
+10,600
New +$30.2K ﹤0.01% 12302
2025
Q1 		– Sell
-87,100
Closed -$307K – 12368
2024
Q4 		$307K Buy
87,100
+19,200
+28% +$87K ﹤0.01% 9787
2024
Q3 		$322K Sell
67,900
-58,100
-46% -$265K ﹤0.01% 9452
2024
Q2 		$592K Sell
126,000
-50,600
-29% -$244K ﹤0.01% 7861
2024
Q1 		$804K Buy
176,600
+148,700
+533% +$660K ﹤0.01% 7399
2023
Q4 		$115K Buy
+27,900
New +$122K ﹤0.01% 11214
2023
Q3 		– Sell
-50,900
Closed -$264K – 11919
2023
Q2 		$264K Sell
50,900
-18,000
-26% -$126K ﹤0.01% 9702
2023
Q1 		$469K Buy
+68,900
New +$327K ﹤0.01% 8719
2022
Q3 		– Sell
-15,200
Closed -$74K – 13060
2022
Q2 		$74K Sell
15,200
-21,400
-58% -$145K ﹤0.01% 11725
2022
Q1 		$277K Buy
36,600
+16,100
+79% +$120K ﹤0.01% 10465
2021
Q4 		$159K Buy
+20,500
New +$161K ﹤0.01% 11723
2015
Q3 		– Sell
-11
Closed -$58K – 9569
2015
Q2 		$58K Buy
11
+3
+38% +$14.9K ﹤0.01% 9843
2015
Q1 		$38K Hold
8
– – ﹤0.01% 9195
2014
Q4 		$39K Sell
8
-15
-65% -$73.3K ﹤0.01% 9406
2014
Q3 		$135K Sell
23
-21
-48% -$146K ﹤0.01% 8953
2014
Q2 		$359K Sell
44
-13
-23% -$160K ﹤0.01% 8081
2014
Q1 		$1.48M Buy
+57
New +$1.4M ﹤0.01% 4820
2013
Q3 		– Sell
-8
Closed -$162K – 8343
2013
Q2 		$162K Buy
+8
New +$179K ﹤0.01% 7580

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Jeff Yass's ACHV Position: Q2 2026 in Review

Jeff Yass reduced its Achieve Life Sciences (ACHV) stake by 92% in Q2 2026, selling an estimated $1.68M and leaving 30,372 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #11961.

Jeff Yass first reported a position in ACHV in Q4 2013 and has held it in 31 quarters since. The position peaked at $2.47M in Q4 2025. 110 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Jeff Yass held 30,372 shares of Achieve Life Sciences worth $198K as of Q2 2026.
  • Jeff Yass sold 353,311 Achieve Life Sciences shares in Q2 2026, an estimated $1.68M.
  • Achieve Life Sciences made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11961 holding.
  • Jeff Yass first reported a position in Achieve Life Sciences in Q4 2013 and has held it in 31 quarters since.
  • Jeff Yass's Achieve Life Sciences position peaked at $2.47M in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.